Clinical Trial Update: Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trials evaluating tolerability, safety, and preliminary clinical effect of ARK-E021 Foam in patients with acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ARK-E021 Foam

Snippet

Sponsor: M. Arkin 1999 Ltd. | Conditions: Acne Vulgaris | Phase 1, Phase 2 | Status: COMPLETED